PPT-Mitigating Stroke Risk in TAVR:
Author : celsa-spraggs | Published Date : 2018-02-18
Important Considerations as TAVR Moves to LowerRisk Patients Benjamin Z Galper MD MPH Brigham amp Womens Hospital Boston MA Consequences of Stroke Mortality TAVR
Presentation Embed Code
Download Presentation
Download Presentation The PPT/PDF document "Mitigating Stroke Risk in TAVR:" is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
Mitigating Stroke Risk in TAVR:: Transcript
Important Considerations as TAVR Moves to LowerRisk Patients Benjamin Z Galper MD MPH Brigham amp Womens Hospital Boston MA Consequences of Stroke Mortality TAVR patients suffering a VARC2 disabling stroke have significantly higher mortality rates compared to patients without stroke 1year mortality of 67 vs 12 and 2year mortality of 83 vs 20. 1 cause of stroke Know your blood pressure and have it checked at least once every two years If its consistently 14090 or above its high Talk to your doctor about how to manage it 4AUE Tobacco use damages blood vessels Dont smoke and avoid secondhan Overview of Anticoagulation in . Interventional Cardiology. Rivaroxaban in Patients With Recent ACS:. ATLAS ACS 2-TIMI 51. Apixaban After ACS: APPRAISE-2. How Do You Treat Complex Patients?. ACC/AHA Guidelines. National Stroke Association. ADVOCATE. – Influence public policy and legislation on stroke survivor issues.. EDUCATE. – Spread the word about stroke awareness.. PARTICIPATE. – Get involved and make a difference in the world of stroke.. Stanton J Rowe. CEO. NXT Biomedical. I, Stanton Rowe, DO have a financial interest/arrangement . or affiliation with one or more organizations that could be perceived as a real or apparent conflict of interest in the context of the subject of this presentation.. ”. Muhammad Raza, MD, FACC, FSCAI, RPVI.. Interventional cardiologist. Director, Cardiac Cath Lab, . Crozer. Chester Medical Center,. Upland, PA. . Disclosure. Consultant and Proctor – Medtronic. Michael Mack, MD. Baylor Scott & White Health. Dallas, TX. How Have Most Operators and Centers Been Trained in Structural Heart?. 3. Do We Need Formal “Structured” Training in Structural Heart?. There are two types of strokes . –. . ischaemic. (clot) and . haemorrhagic. (bleed). . About 85% of all strokes are . ischaemic. and 15% . haemorrhagic. How often does stroke strike?. Occurs 152,00 times a year in the UK . Nicolas M. Van Mieghem, MD, PhD. For the SURTAVI Trial . Investigators. 0. Disclosure Statement of Financial Interests. Within the past 12 months, I have had a financial interest/arrangement or affiliation with the organization(s) list below. No evidence that AF type significantly impacts stroke risk. Scandinavian follow-up study of patients treated for paroxysmal (n=855) and permanent AF (n=1126) during 2002 (mean follow-up 3.6 years) . Aim: to investigate differences in stroke risk in the two cohorts. A Heart Team Perspective. Interventional cardiology: . Megan Coylewright, MD MPH FSCAI. Dartmouth-Hitchcock Heart and Vascular Center. Cardiac surgery: . Melissa Levack, MD. Vanderbilt University Medical Center. Shinichi Fukuhara, MD . (. 1,4,5). , Stephane Leung, MD (2,4,5), Daizo Tanaka, MD (3,4), Devraj Sukul, MD (1,5), P. . . Michael Grossman, MD (1,5), Stanley J. Chetcuti, MD (1,5), Chang He, PhD (4,5), Melissa Clark, MSN (4,5), Himanshu J. Patel, MD (1,4,5). Prevalence of post-stroke fatigue. Post-stroke fatigue has been associated with:. 1. Depression and anxiety. Lower levels of physical activity. Possible inflammation. Post-stroke fatigue improves in approximately . Low-risk Randomized Trial. Michael J. Mack, . MD & . Martin B. Leon, MD. on behalf of the PARTNER 3 Trial Investigators. Disclosures - Michael J. Mack, MD. ACC 2020; Chicago, IL; March 28–30, 2020. Evolut. Low Risk Bicuspid Study. Basel Ramlawi, MD, FACC. Valley Health System, Winchester, Virginia. For the . Evolut. Low Risk Bicuspid Investigators. Disclosure Statement of Financial Interests.
Download Document
Here is the link to download the presentation.
"Mitigating Stroke Risk in TAVR:"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.
Related Documents